Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06187402 · ClinicalTrials.gov registry record · Phase 1

A Study of LM-24C5 For Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by LaNova Medicines Limited.

Recruiting
Registry status
Phase 1
Development phase
49
Enrollment target
6
Study locations

NCT06187402 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by LaNova Medicines Limited. The registered enrollment target is 49 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (75% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06187402, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by LaNova Medicines Limited.

RECRUITING
Registry status
Phase 1
Development phase
49 participants
Enrollment target
6
Study locations

Study Summary

To assess the safety and tolerability, obtain the recommended phase 2 dose (RP2D)/optimal biologic dose (OBD) and/or Maximum Tolerated Dose (MTD) for LM-24C5 in subjects with advanced solid tumors.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG LM-24C5

Study Locations (6)

California

  • University of Southern California (USC) - Norris Comprehensive Cancer Center - Los Angeles

Florida

  • Ocala Oncology - Ocala

Indiana

  • Indiana University Melvan and Bren Simon Cancer Center - Indianapolis

Ohio

  • The Christ Hospital - Cincinnati

Texas

  • Mary Crowley Cancer Research Center - Dallas

Virginia

  • Virginia Cancer Specialists, P.C. - Fairfax

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2023-12-20
Est. Completion 2026-12-30
Phase Phase 1

Sponsor

LaNova Medicines Limited

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06187402

The ClinicalTrials.gov registry entry for NCT06187402 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (75% lower). The listed sponsor is LaNova Medicines Limited, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which LM-24C5 is the first listed.

NCT06187402 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Indiana.

Frequently Asked Questions

What is clinical trial NCT06187402 about?

NCT06187402 is a clinical study titled "A Study of LM-24C5 For Advanced Solid Tumors". To assess the safety and tolerability, obtain the recommended phase 2 dose (RP2D)/optimal biologic dose (OBD) and/or Maximum Tolerated Dose (MTD) for LM-24C5 in subjects with advanced solid tumors.

What is the current status of trial NCT06187402?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2023-12-20. Estimated completion is 2026-12-30.

What conditions does trial NCT06187402 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT06187402?

The interventions under investigation include: LM-24C5 (DRUG).

Who is sponsoring clinical trial NCT06187402?

This trial is sponsored by LaNova Medicines Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06187402 being conducted?

This trial has 6 study locations across California, Florida, Indiana, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.